Shandong Dongyue Organosilicon Mat (300821) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
Shandong Dongyue Organosilicon Mat (300821) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥113.28 Million) in capital expenditures (CN¥99.20K). See 300821 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥113.28 Million
CNY
Capital Expenditures
CN¥99.20K
CNY
Data as of
Jun 2025
Most recent filing
Shandong Dongyue Organosilicon Mat Capital Reinvestment Ratio (2015–2025)
This chart tracks Shandong Dongyue Organosilicon Mat's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Shandong Dongyue Organosilicon Mat (2015–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Dongyue Organosilicon Mat from 2015 to 2025. For live market cap and broader valuation context, see Shandong Dongyue Organosilicon Mat stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥216.73 Million | CN¥21.41 Million | ▲ +27.8% |
| 2024 | 0.08x | CN¥216.37 Million | CN¥16.73 Million | ▼ -98.2% |
| 2022 | 4.25x | CN¥134.89 Million | CN¥573.34 Million | ▲ +109.9% |
| 2021 | 2.02x | CN¥554.57 Million | CN¥1.12 Billion | ▲ +149.8% |
| 2020 | 0.81x | CN¥209.91 Million | CN¥170.12 Million | ▲ +1007.2% |
| 2019 | 0.07x | CN¥513.10 Million | CN¥37.56 Million | ▼ -48.1% |
| 2018 | 0.14x | CN¥810.79 Million | CN¥114.45 Million | ▲ +19.0% |
| 2017 | 0.12x | CN¥408.31 Million | CN¥48.45 Million | ▼ -69.1% |
| 2016 | 0.38x | CN¥31.30 Million | CN¥12.02 Million | ▲ +263.6% |
| 2015 | 0.11x | CN¥123.40 Million | CN¥13.04 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow